Factors associated with discontinuation of biologics in patients with inflammatory arthritis in remission: data from the BIOBADASER registry.
Marta ValeroCarlos Sánchez-PiedraMercedes FreireMaría ColazoNoemí BusquetsErardo Meriño-IbarraCarlos Rodríguez-LozanoSara ManriqueCristina CamposFernando Sánchez-AlonsoIsabel CastrejonPublished in: Arthritis research & therapy (2023)
Discontinuation of bDMARDs in patients who achieve remission is uncommon in routine clinical care. Smoking and positive ACPA in RA patients were associated with a lower probability of treatment discontinuation because of clinical remission.
Keyphrases
- disease activity
- rheumatoid arthritis
- end stage renal disease
- ejection fraction
- healthcare
- palliative care
- ulcerative colitis
- chronic kidney disease
- systemic lupus erythematosus
- oxidative stress
- big data
- machine learning
- quality improvement
- combination therapy
- patient reported
- systemic sclerosis
- interstitial lung disease